Skip to main content
ANAB
NASDAQ Life Sciences

Officer Dennis Mulroy Files to Sell Additional $1.1M in Stock

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$56.07
Mkt Cap
$1.632B
52W Low
$11.402
52W High
$72.36
52W Position info
392% above low
Off High info
23% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

ANAB has more than doubled off its 52-week low of $11.402.

Summary

AnaptysBio officer Dennis Mulroy has filed to sell another $1.1 million in company stock, extending a recent trend of significant insider dispositions that contrasts with the company's share repurchase program.


Key Events · Ownership and Investor Activity · ANAB

  • Officer Files Intent to Sell

    Officer Dennis Mulroy has filed a Form 144 to sell 20,000 shares of common stock, valued at approximately $1,105,940.

  • Continuation of Selling Pattern

    This filing extends a recent trend of significant insider selling by Mulroy, who has sold over $15 million in shares in the past three months.

  • Acquisition via Stock Option Exercise

    The shares intended for sale were acquired through a stock option exercise on the same day as the proposed sale.

  • Contrasts with Share Repurchase Program

    The ongoing insider selling occurs despite the company's recent announcement of a $100 million share repurchase program on May 12, 2026.


Analysis · ANAB · Life Sciences

Officer Dennis Mulroy has filed a Form 144 to sell an additional $1.1 million worth of common stock. This continues a pattern of significant insider selling from Mulroy, who has already sold over $15 million in shares in the past three months. This ongoing selling by a key officer contrasts with the company's recent announcement of a $100 million share repurchase program.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ANAB was trading at $56.07 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.6B. The 52-week trading range was $11.40 to $72.36. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ANAB - Latest Insights

ANAB
Nov 18, 2026, 7:03 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $47.74
Real-time Price: $46.63 info
Change: -$1.11 (-2%) info
Market Cap: $1.386B info
ANAB
Nov 18, 2026, 6:56 PM EST
Filing Type: 4
Importance Score:
8
Price at Filing: $47.06
Real-time Price: $46.63 info
Change: -$0.430 (-0.91%) info
Market Cap: $1.386B info
ANAB
Nov 12, 2026, 4:21 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $47.77
Real-time Price: $46.63 info
Change: -$1.14 (-2%) info
Market Cap: $1.386B info
ANAB
Nov 12, 2026, 4:16 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $47.77
Real-time Price: $46.63 info
Change: -$1.14 (-2%) info
Market Cap: $1.386B info
ANAB
Oct 20, 2026, 3:49 PM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $45.00
Real-time Price: $46.63 info
Change: +$1.63 (+4%) info
Market Cap: $1.386B info